Alliance for Clinical Trials in Oncology
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 251
- Market Cap
- -
Fludarabine and Monoclonal Antibody Therapy in Treating Patients With Untreated B-cell Chronic Lymphocytic Leukemia
- First Posted Date
- 2004-09-10
- Last Posted Date
- 2016-07-20
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 104
- Registration Number
- NCT00003248
- Locations
- 🇺🇸
Marlene & Stewart Greenebaum Cancer Center, University of Maryland, Baltimore, Maryland, United States
🇺🇸Ellis Fischel Cancer Center - Columbia, Columbia, Missouri, United States
🇺🇸North Shore University Hospital, Manhasset, New York, United States
Tetracycline in Preventing Skin Rash in Patients Who Are Receiving Drugs Such as Gefitinib and Cetuximab for Cancer
- Conditions
- Unspecified Adult Solid Tumor, Protocol Specific
- Interventions
- Other: placebo
- First Posted Date
- 2004-09-09
- Last Posted Date
- 2017-03-16
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 130
- Registration Number
- NCT00091247
- Locations
- 🇺🇸
St. Luke's Hospital, Maumee, Ohio, United States
🇺🇸Fredericksburg Oncology, Incorporated, Fredericksburg, Virginia, United States
🇺🇸Saint Anthony Memorial Health Centers, Michigan City, Indiana, United States
Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis
- Conditions
- Sarcoma
- Interventions
- Procedure: conventional surgeryRadiation: radiation therapy
- First Posted Date
- 2004-09-09
- Last Posted Date
- 2016-07-06
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 370
- Registration Number
- NCT00091351
- Locations
- 🇺🇸
McKay-Dee Hospital Center, Ogden, Utah, United States
🇺🇸UVMC Cancer Care Center at Upper Valley Medical Center, Troy, Ohio, United States
🇺🇸Massachusetts General Hospital Cancer Center, Boston, Massachusetts, United States
Irinotecan in Treating Patients With Recurrent Glioma
- Conditions
- Brain and Central Nervous System Tumors
- Interventions
- First Posted Date
- 2004-09-06
- Last Posted Date
- 2016-12-07
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 64
- Registration Number
- NCT00003134
- Locations
- 🇺🇸
Siouxland Hematology-Oncology, Sioux City, Iowa, United States
🇺🇸CCOP - Geisinger Clinical and Medical Center, Danville, Pennsylvania, United States
🇺🇸CCOP - Duluth, Duluth, Minnesota, United States
Glutamine in Preventing Acute Diarrhea in Patients With Pelvic Cancer
- Conditions
- Cancer
- Interventions
- Dietary Supplement: glutamineOther: placebo
- First Posted Date
- 2004-09-06
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 129
- Registration Number
- NCT00003170
- Locations
- 🇺🇸
CCOP - Carle Cancer Center, Urbana, Illinois, United States
🇺🇸CCOP - Duluth, Duluth, Minnesota, United States
🇺🇸CentraCare Clinic, Saint Cloud, Minnesota, United States
Combination Chemotherapy in Treating Patients With Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2004-09-06
- Last Posted Date
- 2020-04-29
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 2005
- Registration Number
- NCT00003088
- Locations
- 🇺🇸
CCOP - Scottsdale Oncology Program, Scottsdale, Arizona, United States
🇺🇸CCOP - Carle Cancer Center, Urbana, Illinois, United States
🇺🇸CCOP - Duluth, Duluth, Minnesota, United States
Aspirin in Treating Patients With Colorectal Cancer That Has Been Surgically Removed
- First Posted Date
- 2004-08-31
- Last Posted Date
- 2016-07-04
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 635
- Registration Number
- NCT00002527
- Locations
- 🇺🇸
CCOP - Sioux Community Cancer Consortium, Sioux Falls, South Dakota, United States
🇺🇸University of Chicago Cancer Research Center, Chicago, Illinois, United States
🇺🇸CCOP - Carle Cancer Center, Urbana, Illinois, United States
Talc in Treating Patients With Malignant Pleural Effusion
- First Posted Date
- 2004-08-31
- Last Posted Date
- 2016-06-28
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 501
- Registration Number
- NCT00002622
- Locations
- 🇺🇸
Allegheny University Hospitals- Hahnemann, Philadelphia, Pennsylvania, United States
🇺🇸Kimmel Cancer Center of Thomas Jefferson University - Philadelphia, Philadelphia, Pennsylvania, United States
🇺🇸Northwestern Memorial Hospital, Chicago, Illinois, United States
Cladribine in Patients With Mantle Cell Lymphoma
- First Posted Date
- 2004-08-24
- Last Posted Date
- 2016-12-07
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 51
- Registration Number
- NCT00002879
- Locations
- 🇺🇸
CentraCare Clinic, Saint Cloud, Minnesota, United States
🇺🇸Quain & Ramstad Clinic, P.C., Bismarck, North Dakota, United States
🇺🇸Altru Health Systems, Grand Forks, North Dakota, United States
Docetaxel, Capecitabine, and Bevacizumab in Treating Patients With Metastatic Breast Cancer
- Conditions
- Breast Cancer
- Interventions
- First Posted Date
- 2004-08-05
- Last Posted Date
- 2016-12-07
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 46
- Registration Number
- NCT00088998